Kazuko Matsuda
Medicinova Inc · MediciNova, Inc. · MediciNova
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kazuko Matsuda as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04429555 · Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSMediciNova · completed · Pneumonia, Viral · study chair
- Ph1/Ph2NCT03782415 · Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaMediciNova · completed · Glioblastoma, Recurrent Glioblastoma, GBM · study director
- Ph2NCT02681055 · Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD SubjectsMediciNova · completed · Non-alcoholic Steatohepatitis, Hypertriglyceridemia, Non-alcoholic Fatty Liver Disease · study chair
- Ph2NCT00838591 · Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of AsthmaMediciNova · completed · Asthma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:45 UTC. The ranking covers the 200 most relevant of 115 PubMed records, and a shared surname and initials can bring in a namesake. All 115 on PubMed
- 371 citationsRCR 12.2
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.N Engl J Med · 2018230 citationsRCR 9.7
- Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.Circulation · 2022204 citationsRCR 17.6
- Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy.Gastrointest Endosc · 2001173 citationsRCR 6.5
- A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder.Mol Psychiatry · 2018159 citationsRCR 5.8
- Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.Gastroenterology · 2016148 citationsRCR 6.5
- 120 citationsRCR 3.4
- Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.Hum Gene Ther · 2008115 citationsRCR 2.0
- Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.Am J Hypertens · 1995110 citationsRCR 3.3
- Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.J Am Coll Cardiol · 200789 citationsRCR 2.2